1. Dang, Ruoyu, Qu, Bojian, Guo, Kaimin, Lin, Jianping, Hu, Yunhui. 2022. Weighted Co-Expression Network Analysis Identifies RNF181 as a Causal Gene of Coronary Artery Disease. In Frontiers in genetics, 12, 818813. doi:10.3389/fgene.2021.818813. https://pubmed.ncbi.nlm.nih.gov/35222523/
2. Zhu, Jian, Li, Xin, Su, Peng, Zang, Yifeng, Ding, Yinlu. 2020. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression. In Oncogene, 39, 6776-6788. doi:10.1038/s41388-020-01464-z. https://pubmed.ncbi.nlm.nih.gov/32973333/
3. Zhou, Rui, Ding, Yinlu, Xue, Min, Xiong, Bin, Zhuang, Ting. 2020. RNF181 modulates Hippo signaling and triple negative breast cancer progression. In Cancer cell international, 20, 291. doi:10.1186/s12935-020-01397-3. https://pubmed.ncbi.nlm.nih.gov/32655323/
4. Wang, Tian-Tian, Hong, Ying-Fen, Chen, Zhan-Hong, Zhang, Qi, Jia, Chang-Chang. 2021. Synergistic effects of α-Mangostin and sorafenib in hepatocellular carcinoma: New insights into α-mangostin cytotoxicity. In Biochemical and biophysical research communications, 558, 14-21. doi:10.1016/j.bbrc.2021.04.047. https://pubmed.ncbi.nlm.nih.gov/33894673/
5. Li, Ya, Xiang, Zhao-Yan, Xiong, Jie, Zhu, Zhu, Bao, Wei-Wei. 2021. RN181 regulates the biological behaviors of oral squamous cell carcinoma cells via mediating ERK/MAPK signaling pathway. In Acta histochemica, 123, 151733. doi:10.1016/j.acthis.2021.151733. https://pubmed.ncbi.nlm.nih.gov/34052676/
6. Wang, Suihai, Wang, Xiaobo, Gao, Yanjun, Li, Ming, Li, Ji-Liang. 2019. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway. In The Journal of pathology, 248, 204-216. doi:10.1002/path.5246. https://pubmed.ncbi.nlm.nih.gov/30714150/